Market Place
Sourcing Support
All News #Library
Biogen Canada`s Zurzuvae Approved in Canada
05 Dec 2025 //
HEALTH CANADA
Biogen`s Biologic Tysabri Receives Suppl Approval in US
18 Mar 2025 //
FDA
Biogen`s Skyclarys Receives Approval in Canada
13 Mar 2025 //
HEALTH CANADA
Biogen`s Tofidence (tocilizumab) Receives Approval in Europe
20 Jun 2024 //
EMA
Biogen`s Biologic Tysabri (natalizumab) Receives Approval in the U.S.
30 Oct 2023 //
FDA
Biogen`s Biologic Tysabri (Natalizumab) Receives Approval in the U.S.
11 Apr 2023 //
FDA
Biogen`s Biologic ADUHELM (Aducanumab) Receives Approval in the U.S.
08 Feb 2023 //
FDA
Biogen`s Aducanumab Receives Supplemental Approval in U.S.
29 Apr 2022 //
FDA
Biogen`s Avonex (Interferon beta-1a Receives Supplemental Approvals in US
05 Nov 2021 //
FDA
Biogen Idec`s Biological Natalizumab Receives Approval In US
05 Oct 2020 //
FDA
Biogen Idec`s Tysabri (Natalizumab) Receives Supplemental Approval In US
24 Jun 2020 //
FDA
Biogen Idec`s Tysabri (Natalizumab) Receives Supplemental Approval In US
25 Apr 2020 //
FDA
Biogen`s Plegridy (Interferon Beta-1A) Receives Supplemental Approval In US
31 Mar 2020 //
FDA
Biogen`s Avonex (Interferon Beta-1A) Receives Supplemental Approval In US
16 Jul 2019 //
FDA
Biogen`s Tysabri (Natalizumab) Receives Approval in US
07 Jan 2019 //
FDA
Biogen`s Tecfidera (dimethyl fumarate) Receives Approval in Europe
12 Oct 2018 //
EMA
Biogen`s Zinbryta (Daclizumab) Receives Supplemental Approval In US
31 Aug 2017 //
FDA
Biogen Idec’s Tysabri Natalizumab Receives Supplemental Approval In US
18 Aug 2017 //
FDA
Biogen Idec`s Spinraza (nusinersen) Receives Approval In Europe
21 Jun 2017 //
EMA
Biogen`s Zinbryta (Daclizumab) approved in US for Multiple Sclerosis
27 May 2016 //
FDA
Biogen`s Zinbryta receives market authorisation in EU for Multiple Sclerosis
28 Apr 2016 //
EMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.